NCI’s Problems With FDA Appear To Be Resolved With Agreement on Drug Distribution System
In Brief: DeVita, FDA Chief Help Kill California Bill Legalizing Laetrile Wit committee Testimony
Bioassay Backlog Catch Up Planned By Mid-February
NCI Advisory Group, Other Cancer Meetings
“Whatever Happened To…?” ACS Follows Up Five Years Later
Trending Stories
- FDA’s second rejection of Replimune’s melanoma treatment stirs worry among oncologists, patients
“Patients are owed another review.” - Mayo Clinic AI detects pancreatic cancer up to three years before diagnosis, validation study finds
- By adding specialists to USPSTF, Kennedy would reshape the functioning and decisions of the influential health panel
Ransohoff: “The task force’s job is to describe the evidence fairly, and that’s done best with objective, detached methodologists” - ASCO & The Conquer Cancer Foundation announce merit awards
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- Benjamin Ebert, Amy Gladfelter, Stephen Liberles, and Pardis Sabeti are among new members of the National Academy of Sciences









